BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31591606)

  • 1. Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
    Joshi K; de Massy MR; Ismail M; Reading JL; Uddin I; Woolston A; Hatipoglu E; Oakes T; Rosenthal R; Peacock T; Ronel T; Noursadeghi M; Turati V; Furness AJS; Georgiou A; Wong YNS; Ben Aissa A; Sunderland MW; Jamal-Hanjani M; Veeriah S; Birkbak NJ; Wilson GA; Hiley CT; Ghorani E; Guerra-Assunção JA; Herrero J; Enver T; Hadrup SR; Hackshaw A; Peggs KS; McGranahan N; Swanton C; ; Quezada SA; Chain B
    Nat Med; 2019 Oct; 25(10):1549-1559. PubMed ID: 31591606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.
    Parkhurst M; Gros A; Pasetto A; Prickett T; Crystal JS; Robbins P; Rosenberg SA
    Clin Cancer Res; 2017 May; 23(10):2491-2505. PubMed ID: 27827318
    [No Abstract]   [Full Text] [Related]  

  • 3. TCR function analysis using a novel system reveals the multiple unconventional tumor-reactive T cells in human breast cancer-infiltrating lymphocytes.
    Yamaguchi S; Hamana H; Shitaoka K; Sukegawa K; Nagata T; Hayee A; Kobayashi E; Ozawa T; Fujii T; Muraguchi A; Tobe K; Kishi H
    Eur J Immunol; 2021 Sep; 51(9):2306-2316. PubMed ID: 34171120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics study revealing the complexity and spatial heterogeneity of tumor-infiltrating lymphocytes in primary liver carcinoma.
    Shi L; Zhang Y; Feng L; Wang L; Rong W; Wu F; Wu J; Zhang K; Cheng S
    Oncotarget; 2017 May; 8(21):34844-34857. PubMed ID: 28422742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between T cell receptor clonotype and PD-1 expression of tumor-infiltrating lymphocytes in colorectal cancer.
    Sukegawa K; Shitaoka K; Hamana H; Kobayashi E; Miyahara Y; Fujii K; Tsuda K; Saeki S; Nagata T; Ozawa T; Saito S; Fujii T; Muraguchi A; Shiku H; Kishi H
    Eur J Immunol; 2020 Oct; 50(10):1580-1590. PubMed ID: 32441316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of T-cell receptor libraries with diverse binding properties to examine adoptive T-cell responses.
    Chervin AS; Stone JD; Soto CM; Engels B; Schreiber H; Roy EJ; Kranz DM
    Gene Ther; 2013 Jun; 20(6):634-44. PubMed ID: 23052828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.
    Gros A; Parkhurst MR; Tran E; Pasetto A; Robbins PF; Ilyas S; Prickett TD; Gartner JJ; Crystal JS; Roberts IM; Trebska-McGowan K; Wunderlich JR; Yang JC; Rosenberg SA
    Nat Med; 2016 Apr; 22(4):433-8. PubMed ID: 26901407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Needle in a Haystack: The Naïve Repertoire as a Source of T Cell Receptors for Adoptive Therapy with Engineered T Cells.
    D'Ippolito E; Wagner KI; Busch DH
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global analysis of T-cell groups reveals immunological features and common antigen targets of digestive tract tumors.
    Li X; Zhang Y; Guo S; Wu Z; Wang H; Huang Y; Wang Y; Qiu M; Lang J; Xiao Y; Zhu Y; Jin G; Hu L; Kong X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):129. PubMed ID: 38488909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy.
    Yossef R; Tran E; Deniger DC; Gros A; Pasetto A; Parkhurst MR; Gartner JJ; Prickett TD; Cafri G; Robbins PF; Rosenberg SA
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells.
    Rudqvist NP; Pilones KA; Lhuillier C; Wennerberg E; Sidhom JW; Emerson RO; Robins HS; Schneck J; Formenti SC; Demaria S
    Cancer Immunol Res; 2018 Feb; 6(2):139-150. PubMed ID: 29180535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD103
    Corgnac S; Malenica I; Mezquita L; Auclin E; Voilin E; Kacher J; Halse H; Grynszpan L; Signolle N; Dayris T; Leclerc M; Droin N; de Montpréville V; Mercier O; Validire P; Scoazec JY; Massard C; Chouaib S; Planchard D; Adam J; Besse B; Mami-Chouaib F
    Cell Rep Med; 2020 Oct; 1(7):100127. PubMed ID: 33205076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CD8 T cell apoptosis and EGFR mutation in non-small lung cancer patients.
    Zhao C; Su C; Li X; Zhou C
    Thorac Cancer; 2020 Aug; 11(8):2130-2136. PubMed ID: 32500560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza virus-specific TCR-transduced T cells as a model for adoptive immunotherapy.
    Berdien B; Reinhard H; Meyer S; Spöck S; Kröger N; Atanackovic D; Fehse B
    Hum Vaccin Immunother; 2013 Jun; 9(6):1205-16. PubMed ID: 23428899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
    Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J
    Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes.
    Shah P; Forget MA; Frank ML; Jiang P; Sakellariou-Thompson D; Federico L; Khairullah R; Neutzler CA; Wistuba I; Chow CB; Long Y; Fujimoto J; Lin SY; Maitra A; Negrao MV; Mitchell KG; Weissferdt A; Vaporciyan AA; Cascone T; Roth JA; Zhang J; Sepesi B; Gibbons DL; Heymach JV; Haymaker CL; McGrail DJ; Reuben A; Bernatchez C
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35110355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue.
    Sherwood AM; Emerson RO; Scherer D; Habermann N; Buck K; Staffa J; Desmarais C; Halama N; Jaeger D; Schirmacher P; Herpel E; Kloor M; Ulrich A; Schneider M; Ulrich CM; Robins H
    Cancer Immunol Immunother; 2013 Sep; 62(9):1453-61. PubMed ID: 23771160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive CD8
    Jiang X; Xu J; Liu M; Xing H; Wang Z; Huang L; Mellor AL; Wang W; Wu S
    Cancer Lett; 2019 Oct; 462():23-32. PubMed ID: 31356845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCR repertoire intratumor heterogeneity of CD4
    Zhang C; Ding H; Huang H; Palashati H; Miao Y; Xiong H; Lu Z
    Int J Cancer; 2019 Feb; 144(4):818-827. PubMed ID: 30151844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.